1. Home
  2. CTMX vs BZH Comparison

CTMX vs BZH Comparison

Compare CTMX & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$5.97

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Logo Beazer Homes USA Inc.

BZH

Beazer Homes USA Inc.

HOLD

Current Price

$25.05

Market Cap

672.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTMX
BZH
Founded
2008
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
596.2M
672.0M
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
CTMX
BZH
Price
$5.97
$25.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
3
Target Price
$8.86
$32.00
AVG Volume (30 Days)
3.7M
625.0K
Earning Date
03-05-2026
01-29-2026
Dividend Yield
N/A
N/A
EPS Growth
50.22
N/A
EPS
0.24
0.33
Revenue
$113,631,000.00
$2,266,093,000.00
Revenue This Year
N/A
$8.45
Revenue Next Year
N/A
$12.21
P/E Ratio
$23.67
$75.15
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$17.37
52 Week High
$6.35
$27.29

Technical Indicators

Market Signals
Indicator
CTMX
BZH
Relative Strength Index (RSI) 54.53 60.28
Support Level $5.17 $20.31
Resistance Level $6.35 $24.96
Average True Range (ATR) 0.50 1.07
MACD -0.05 0.06
Stochastic Oscillator 29.01 92.27

Price Performance

Historical Comparison
CTMX
BZH

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.

Share on Social Networks: